Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |